Statistical issues and challenges in immuno-oncology

Autor Chen, Tai-Tsang
Vydáno 2013

Predicting analysis times in randomized clinical trials with cancer immunotherapy

Autor Chen, Tai-Tsang
Vydáno v BMC Med Res Methodol (2016)

Milestone Survival: A Potential Intermediate Endpoint for Immune Checkpoint Inhibitors

Autor Chen, Tai-Tsang
Vydáno v J Natl Cancer Inst (2015)

Differential effects of dosing regimen on the safety and efficacy of dasatinib: retrospective exposure–response analysis of a Phase III study

Autor Wang, Xiaoning, Roy, Amit, Hochhaus, Andreas, Kantarjian, Hagop M, Chen, Tai-Tsang, Shah, Neil P
Vydáno 2013

Dasatinib Early Intervention After Cytogenetic or Hematologic Resistance to Imatinib in Patients With Chronic Myeloid Leukemia

Autor Quintás-Cardama, Alfonso, Cortes, Jorge E., O'Brien, Susan, Ravandi, Farhad, Borthakur, Gautam, Liu, David, Bleickardt, Eric, Chen, Tai-Tsang, Kantarjian, Hagop M.
Vydáno 2009

Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma

Autor Schadendorf, Dirk, Hodi, F. Stephen, Robert, Caroline, Weber, Jeffrey S., Margolin, Kim, Hamid, Omid, Patt, Debra, Chen, Tai-Tsang, Berman, David M., Wolchok, Jedd D.
Vydáno v J Clin Oncol (2015)

Five-Year Survival Rates for Treatment-Naive Patients With Advanced Melanoma Who Received Ipilimumab Plus Dacarbazine in a Phase III Trial

Autor Maio, Michele, Grob, Jean-Jacques, Aamdal, Steinar, Bondarenko, Igor, Robert, Caroline, Thomas, Luc, Garbe, Claus, Chiarion-Sileni, Vanna, Testori, Alessandro, Chen, Tai-Tsang, Tschaika, Marina, Wolchok, Jedd D.
Vydáno v J Clin Oncol (2015)

Ipilimumab efficacy and safety in patients with advanced melanoma: a retrospective analysis of HLA subtype from four trials

Autor Wolchok, Jedd D., Weber, Jeffrey S., Hamid, Omid, Lebbé, Celeste, Maio, Michele, Schadendorf, Dirk, de Pril, Veerle, Heller, Kevin, Chen, Tai-Tsang, Ibrahim, Ramy, Hoos, Axel, O'Day, Steven J.
Vydáno 2010

Rejoinder to Letter to the Editor “The Hazards of Period Specific and Weighted Hazard Ratios”

Autor Lin, Ray S., Lin, Ji, Roychoudhury, Satrajit, Anderson, Keaven M., Hu, Tianle, Huang, Bo, Leon, Larry F., Liao, Jason J. Z., Liu, Rong, Luo, Xiaodong, Mukhopadhyay, Pralay, Qin, Rui, Tatsuoka, Kay, Wang, Xuejing, Wang, Yang, Zhu, Jian, Chen, Tai-Tsang, Iacona, Renee
Vydáno v Stat Biopharm Res (2020)